Jane Street’s Coya Therapeutics COYA Stock Holding History

Jane Street’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.6K	Sell	13,340 -20,484	-61%	-$95.8K	﹤0.01%	10954
2025 Q4	$196K	Buy	+33,824	New	+$206K	﹤0.01%	9739
2025 Q3	–	Sell	-26,540	Closed	-$153K	–	10883
2025 Q2	$153K	Buy	26,540 +403	+2%	+$2.33K	﹤0.01%	8736
2025 Q1	$169K	Buy	26,137 +13,176	+102%	+$83.4K	﹤0.01%	8565
2024 Q4	$74.3K	Buy	+12,961	New	+$88.3K	﹤0.01%	8864
2024 Q2	–	Sell	-20,078	Closed	-$199K	–	9464
2024 Q1	$199K	Buy	+20,078	New	+$157K	﹤0.01%	8187

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's COYA Position: Q1 2026 in Review

Jane Street reduced its Coya Therapeutics (COYA) stake by 61% in Q1 2026, selling an estimated $95.8K and leaving 13,340 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10954.

Jane Street first reported a position in COYA in Q1 2024 and has held it in 6 quarters since. The position peaked at $199K in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

Jane Street held 13,340 shares of Coya Therapeutics worth $52.6K as of Q1 2026.
Jane Street sold 20,484 Coya Therapeutics shares in Q1 2026, an estimated $95.8K.
Coya Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10954 holding.
Jane Street first reported a position in Coya Therapeutics in Q1 2024 and has held it in 6 quarters since.
Jane Street's Coya Therapeutics position peaked at $199K in Q1 2024.
56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.